ING Groep NV Purchases Shares of 6,036 The Cooper Companies, Inc. (NASDAQ:COO)

ING Groep NV purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund purchased 6,036 shares of the medical device company’s stock, valued at approximately $555,000.

Other large investors have also added to or reduced their stakes in the company. Ashton Thomas Securities LLC purchased a new stake in Cooper Companies during the 3rd quarter valued at about $25,000. Byrne Asset Management LLC acquired a new position in shares of Cooper Companies in the 4th quarter valued at about $33,000. Covestor Ltd lifted its holdings in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares during the period. Brown Brothers Harriman & Co. raised its holdings in Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after purchasing an additional 275 shares during the period. Finally, West Financial Advisors LLC acquired a new position in Cooper Companies in the 4th quarter worth about $49,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the company. Citigroup reduced their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Morgan Stanley reduced their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Stock Performance

NASDAQ COO opened at $90.06 on Tuesday. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The business’s 50 day moving average is $92.86 and its two-hundred day moving average is $99.63. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38. The stock has a market capitalization of $17.97 billion, a price-to-earnings ratio of 46.18, a PEG ratio of 2.25 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm’s quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.87 EPS. Research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.